Galectin Therapeutics Inc. (GALT)

[thruthster101]

On February 12, 2009, Peter Traber, M.D., was named a member of the Board of Directors. Dr. Traber is President Emeritus and former Chief Executive Officer of Baylor College of Medicine. Previously, Dr. Traber was Senior Vice President Clinical Development and Regulatory Affairs and Chief Medical Officer of GlaxoSmithKline plc. He has also served as Chief Executive Officer of the University of Pennsylvania Health System, as well as Chair of the Department of Internal Medicine and Chief of Gastroenterology for the University of Pennsylvania School of Medicine

I guess Dr. Traber, among many others, both inside and outside the company, is satisfied that there is clinical merit to Davanat. He hasn't forgotten his involvement and will be present at the Annual Meeting on May 25th. Anyone interested in finding out more can attend the meeting, it is open to all shareholders.